Study Details
Study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer (NSCLC) with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
Clinicaltrials.gov ID
Astellas Study ID
OSI-906-207
EudraCT ID
N/A
Condition
Non Small Cell Lung Cancer
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Apr 2011 - Sep 2014
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
88
A Randomized, Double-Blind, Phase 2 Study of Erlotinib (Tarceva®) in combination with OSI-906 or placebo in Chemonaive Patients with Advanced NSCLC with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer (NSCLC) with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Providence St. Joseph Medical Center
Burbank, United States, 91505
Chao Family Comprehensive Cancer Center - University California
Irvine, United States, 92868
Cleveland Clinic Florida
Weston, United States, 33331
Asan Medical Center
Songpa-gu, Republic of Korea, 138736
Chonnam National University Hwasun Hospital
Ilsimri, Republic of Korea, 519809
Swedish Cancer Institute
Seattle, United States, 98104
Memorial Sloan Kettering Cancer Center
New York, United States, 10021
University of Tennessee Cancer Institute
Memphis, United States, 31804
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, United States, 21231
Johns Hopkins Singapore International Medical Centre
Singapore, Singapore, 308433
Hematology Oncology Associates of the Treasure Coast
Port St. Lucie, United States, 34952
National Cancer Institute
Phayathai, Thailand, 10400
Rush University Medical Center
Chicago, United States, 60612
University of California, San Diego/Moores Cancer Center
La Jolla, United States, 92093
Juravinski Cancer Centre
Hamilton, Canada, L8V 5C2
Mount Elizabeth Medical Centre
Singapore, Singapore, 228510
Karmanos Cancer Institute
Detroit, United States, 48201
London Regional Cancer Program
London, Canada, N6A 4L6
Korea University Anam Hospital
Seoul, Republic of Korea, 136705
Medical University of South Carolina
Charleston, United States, 29425
Songklanagarind Hospital, Prince of Songkla University
Songkla, Thailand, 90110
Pacific Cancer Medical Center
Anaheim, United States, 92801
Seoul National University Bundang Hospital
Seongnam-si, Republic of Korea, 463-707
Bumrungrad Hospital Public Company, Ltd. Clinical Research Center
Bangkok, Thailand, 10110
Oncocare Cancer Center
Singapore, Singapore, 258499
Inha University Hospital
Inchon, Republic of Korea, 400711
Vanderbilt University Medical Center
Nashville, United States, 37232
Samsung Medical Center
Seoul, Republic of Korea, 135710
Princess Margaret Hospital
Toronto, Canada, M5G 2M9
Queen Mary Hospital
Pokfulam, Hong Kong
Pamela Youde Nethersole Eastern Hospital
Chai Wan, Hong Kong, 852
Monrefiore Medical Center
Bronx, United States, 10467
Khon Kaen University
Khon Kaen, Thailand, 40002
University Hospitals of Clevelnd
Cleveland, United States, 44106
Seattle Cancer Care Alliance University of Washington
Seattle, United States, 98109
Jewish General Hospital
Montreal, Canada, H3T 1E2
Gachon University Gil Medical Center
Incheon, Republic of Korea, 405760
Maharaj Nakorn Chiangmai
Chiang Mai, Thailand, 50002
H. Lee Moffitt Cancer Center and Research Institute
Tampa, United States, 33612
Northwestern Memorial Hospital
Chicago, United States, 60611